People
Ludo Van Den Bosch
Ludo Van Den Bosch is Augustine Therapeutics’ scientific founder and chairman of its scientific advisory board. The company was spun out of VIB and KU Leuven in2019 from his HDAC6 research in peripheral neuropathies and neurodegeneration. His VIB–KU Leuven academic affiliation and scientific advisory role are distinct from company executive employment. Ludo Van Den Bosch is named Investment Advisory Board in Droia’s current public directory. The published professional background includes Professor in the Department of Neurosciences at KU Leuven; Group leader at the VIB Center for Brain & Disease Research.; Head of the Laboratory of Neurobiology at VIB; Scientific Founder of Augustine Therapeutics. This is a manager-published affiliation; advisory-board membership and Droia Labs scientific roles are qualified separately from the investment team. Exact appointment dates and personal cash participation are not inferred.
Roles
Scientific Founder
Chairman, Scientific Advisory Board (external academic)
Investment Advisory Board